Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Characteristics of the included studies

From: Association between metabolic syndrome and the risk of glaucoma: a meta-analysis of observational studies

Study

Location

Study design

Population

No. of participants

Mean age (years)

Male (%)

Criteria for the diagnosis of MetS

No. of patients with MetS

Follow-up duration for cohort studies (years)

Methods for the diagnosis of glaucoma

Type of glaucoma

Number of patients with glaucoma

Variables adjusted

Tan 2009

Singapore

CS

Community population aged 40 to 80 years

3278

58.7

48.1

NCEP-ATP III

1347

NA

Clinically diagnosed (as evidenced by ophthalmic examination)

Overall glaucoma and POAG

150

Age, sex, education, smoking status, central corneal thickness, and diabetic treatment

Newman 2011

USA

RC

Community population aged 40 years or older

2,182,315

54.5

43

NCEP-ATP III

343,615

Up to 6 years

ICD codes

POAG

55,090

Age, sex, race, education, SES, cataract, macular degeneration, retinopathy, systemic hypotension, migraine headache, and CCI

Kim 2014

Korea

CS

Community population aged 40 years or older undergoing glaucoma screening

18,240

52.8

56.9

NCEP-ATP III

3635

NA

Clinically diagnosed (as evidenced by ophthalmic examination)

NTG

300

Age, sex, IOP at baseline, and BMI

Zhao 2014

USA

CS

Community population aged 40 years or older

3026

57

46.8

NCEP-ATP III

971

NA

Self-reported glaucoma diagnosed by a doctor

Overall glaucoma

191

Age, sex, ethnicity, smoking, physical activity, alcohol intake, education, and BMI

Rasoulinejad 2015

Iran

CC

POAG patients and healthy control

200

61

38

NCEP-ATP III

91

NA

Clinically diagnosed (as evidenced by ophthalmic examination)

POAG

100

Age, sex, BMI, IOP, and central corneal thickness

Lee 2017

Korea

CS

Community population aged 40 years or older

14,400

56

48.3

NCEP-ATP III

3067

NA

Clinically diagnosed (as evidenced by ophthalmic examination)

NTG

732

Age, sex, BMI, smoking status, refractive status, and education level

Jung 2020

Korea

PC

Community population aged 40 years or older

287,553

NR

49.1

NCEP-ATP III

40,046

11.8

ICD codes

POAG

4970

Age, sex, smoking, alcohol, exercise, income, and residential area

Wu 2022

USA

CS

Community population aged 40 years or older

38,286

NR

42.8

NCEP-ATP III

30,204

NA

ICD codes

Overall glaucoma

4653

Age, sex, race, and smoking history

Lee 2023

Korea

CS

Community population aged 19 years or older

11,499

51.9

49.6

NCEP-ATP III

4384

NA

Clinically diagnosed (as evidenced by ophthalmic examination)

POAG

502

Age, sex, BMI, total energy intake, smoking, alcohol drinking, SES, and IOP

  1. MetS, metabolic syndrome; CS, cross-sectional; CC, case-control; PC, prospective cohort; RC, retrospective cohort; POAG, primary open-angle glaucoma; NCEP-ATP III, National Cholesterol Education Program Adult Treatment Panel III; NR, not reported; NA, not applicable; ICD, International Classification of Diseases; NTG, normal-tension glaucoma; SES, socioeconomic status; CCI, Charlson Comorbidity Index; BMI, body mass index; IOP, intraocular pressure